These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Tang YH, He GL, Huang SZ, Zhong KB, Liao H, Cai L, Gao Y, Peng ZW, Fu SJ. Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320 [Abstract] [Full Text] [Related]
4. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3. Li Z, Wu L, Tan W, Zhang K, Lin Q, Zhu J, Tu C, Lv X, Jiang C. Ann Hepatol; 2021 May; 23():100345. PubMed ID: 33812045 [Abstract] [Full Text] [Related]
5. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X, Zhang P, Pan Y, Liu Y. Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [Abstract] [Full Text] [Related]
6. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Liu W, Yin C, Liu Y. Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066 [Abstract] [Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G, Lin Y, Zhang H, Wu D. Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123 [Abstract] [Full Text] [Related]
8. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y, Wei G, Zhang L, Zhou H, Wang W, Guo P, Cheng C, Ji L, Cai Q, Feng Y, Tu H. Bioengineered; 2021 Dec 31; 12(1):8217-8232. PubMed ID: 34596006 [Abstract] [Full Text] [Related]
9. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Yao J, Fu J, Liu Y, Qu W, Wang G, Yan Z. Ann Hepatol; 2021 Dec 31; 23():100297. PubMed ID: 33346094 [Abstract] [Full Text] [Related]
10. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma. Cheng B, Ding F, Huang CY, Xiao H, Fei FY, Li J. Eur Rev Med Pharmacol Sci; 2019 Jan 31; 23(1):137-145. PubMed ID: 30657555 [Abstract] [Full Text] [Related]
11. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Zhu X, Jiang S, Wu Z, Liu T, Zhang W, Wu L, Xu L, Shao M. Bioengineered; 2021 Dec 31; 12(1):578-588. PubMed ID: 33517826 [Abstract] [Full Text] [Related]
12. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma. Liang Z, Li X, Duan F, Song L, Wang Z, Li X, Yang P, Li L. Hum Cell; 2022 Jan 31; 35(1):299-309. PubMed ID: 34784010 [Abstract] [Full Text] [Related]
13. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1. Li Y, Bai W, Zhang J. Biomed Pharmacother; 2017 Aug 31; 92():1038-1044. PubMed ID: 28609841 [Abstract] [Full Text] [Related]
14. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Shi Y, Yan F, Wang F, Pan L. Tissue Cell; 2021 Oct 31; 72():101534. PubMed ID: 33991762 [Abstract] [Full Text] [Related]
17. Long Noncoding RNA HOTAIR Contributes to Progression in Hepatocellular Carcinoma by Sponging miR-217-5p. Gong X, Zhu Z. Cancer Biother Radiopharm; 2020 Jun 31; 35(5):387-396. PubMed ID: 32315535 [Abstract] [Full Text] [Related]
18. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y, He X. Yonsei Med J; 2019 Mar 31; 60(3):267-276. PubMed ID: 30799589 [Abstract] [Full Text] [Related]
20. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H. Life Sci; 2019 May 01; 224():1-11. PubMed ID: 30876939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]